(Co-located with Protein Expression Europe, 20-21 October)

Antibodies Sessions

Although therapeutic antibodies have come a long way in the past several years, many problems still exist in the production and use of these complex molecules. The negative qualities of these proteins, including immunogenicity, delivery difficulties, and the high cost of production, among others, have made the outcomes of their production and use less than satisfactory. In order to improve or eliminate these negatives, it is critical to find new ways to engineer antibodies, new antibody alternatives (such as mimetics, fragments, etc.) and novel ways to scale up production to provide large amounts of these proteins in a cost-effective way. This conference will present the latest data on how to achieve these improved results and the research data necessary to apply the solutions to your laboratory’s efforts.

Keynote Presentations

Andreas Plückthun
Professor of Biochemistry, University of Zürich, Switzerland

Marlies Sproll, Ph.D.
Chief Scientific Officer, MorphoSys AG, Martinsried

Scientific Advisory Board
Kaspar Binz, Ph.D., Molecular Partners AG
Lutz Jermutus, Ph.D., MedImmune, Inc.